Syapse software enables healthcare providers to deploy precision medicine programs.

Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. Syapse Precision Medicine Platform is a comprehensive software suite used by leading health systems to support the clinical implementation of precision medicine in oncology and other service lines. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point of care. Headquartered in San Francisco, California, with offices in Philadelphia, Pennsylvania, Syapse is backed by Ascension Ventures, Safeguard Scientifics, Social Capital, GE Ventures, and Intermountain Healthcare Innovation Fund I, LP.

Leadership

Ken Tarkoff

CEO

Jonathan Hirsch

President & Founder

Tony Loeser, PhD

CTO & Co-Founder

Dan Baker

SVP, Sales

Andreas Heid

VP, Customer Operations

Trishan Arul

SVP, Finance

Board of Directors

Gary J. Kurtzman, MD

Safeguard Scientifics

John Kuelper

Ascension Ventures

Ted Maidenberg

Social Capital

Jonathan Hirsch

President & Founder

Ken Tarkoff

CEO

Investors